US Patent 9359439 Fab-glycosylated antibodies
Patent 9359439 was granted and assigned to Glycotope GmbH on June, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+315 characters)
Article
Patent abstract
The present invention pertains to a method for controlling the circulation half-life of antibodies by adjusting the amount of sialic acid in the carbohydrates attached to the Fab part of the antibodies. Furthermore, the present invention provides antibodies having an increased circulation half-life.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Antje Danielczyk0
Lars Stoeckl0
Steffen Goletz0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09359439 Fab-glycosylated antibodies US Patent 9359439 Fab-glycosylated antibodies
Infobox
Patent Number
093594390
Patent Number
93594390
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
093594390
Date of Patent
June 7, 2016
0Patent Application Number
138163900
Date Filed
August 10, 2011
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09359439 Fab-glycosylated antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09359439
Date of patent
June 7, 2016
Patent application number
13816390
Date Filed
August 10, 2011
Patent primary examiner
Find more entities like US Patent 9359439 Fab-glycosylated antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
